Use of single maintenance and reliever therapy (SMART) for moderate-to-severe asthma saved money by improving outcomes, according to a meta-analysis. While SMART is recommended by guidelines, ...
Asthma may not be driven by the molecules scientists have blamed for decades. Researchers have identified “pseudo leukotrienes,” inflammation-triggering compounds formed by uncontrolled free-radical ...
Please provide your email address to receive an email when new articles are posted on . Many parents believe children will outgrow wheeze without seeing a specialist. Many patients also underestimate ...
A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...
What Is Exdensur, and Why Does It Matter? Exdensur (depemokimab) is a new type of ultra long-acting biologic medicine approved by the FDA as an add-on maintenance treatment for severe eosinophilic ...
In the Motor City, it’s more than just vehicle exhaust causing problems for people living with asthma. While pollution from vehicle emissions and manufacturing plays a role in exacerbating the ...
When your child has asthma, an asthma action plan can help you respond quickly to symptoms and prevent emergency department visits and hospitalizations. “An asthma action plan … outlines which ...
Managing asthma often requires a two-pronged approach — long-term medicines to prevent attacks and rescue strategies to stop attacks when they happen. It’s important to avoid triggers and monitor ...
Asthma is a respiratory condition that requires individualized care, considering each patient’s unique characteristics and therapeutic opportunities. Both primary care professionals and specialists ...
• Adding a long-acting beta2-agonist (LABA) or a long-acting muscarinic antagonist (LAMA) to medium-dose inhaled corticosteroids (ICS) likely reduces asthma attacks requiring treatment with oral ...
Credit: Getty Images The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as many updated charts and tools. The 2025 update also ...
Esther Bejarano's son was 11 months old when asthma landed him in the hospital. She didn't know what had triggered his symptoms — neither she nor her husband had asthma — but she suspected it was the ...